Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)
NCT07805044 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2026-09-04
Summary
TRU-OMNIBODY is a prospective observational study designed to develop and independently validate a research-only whole-body digital twin. The digital twin will combine measurements from multiple body systems to create a participant-specific representation of physiologic state, resilience, and recovery.
The study plans to enroll approximately 450 adults between 18 and 80 years of age. Participants will include generally healthy adults and adults with stable cardiometabolic, respiratory, or mobility-related conditions. Study measurements may include wearable-sensor data, heart rate and rhythm, blood pressure, oxygen saturation, autonomic responses, body composition, mobility, muscle function, sleep, activity, cognitive performance, point-of-care imaging, laboratory measurements, and optional biospecimens.
Participants will complete a standardized resilience assessment consisting of rest, active standing, a six-minute walk, a cognitive dual task, and monitored recovery. Selected measurements will also be collected during home monitoring and follow-up visits for up to 12 months.
The primary objective is to determine how accurately a locked digital-twin model predicts Whole-Body Recovery Burden, a research measure derived from the timing and magnitude of recovery across several physiologic systems. Model development and testing will be separated so that the final evaluation is performed in an independent validation cohort.
This study does not assign participants to a medical treatment. Digital-twin outputs will not be used to diagnose disease, recommend treatment, or replace evaluation by a qualified health care professional.
Conditions
- PHYSIOLOGICAL PHENOMENA
- Homeostasis
- Physical Functional Performance
- Cardiorespiratory Fitness
- Cardiometabolic Risk Factors
- Mobility Limitation
Interventions
- PROCEDURE
-
Standardized Physiologic Resilience Challenge
Participants will complete a standardized, nontherapeutic sequence that may include baseline rest and stabilization, active standing, a six-minute walk, a cognitive dual task, and monitored recovery. Synchronized physiologic and functional measurements will be collected before, during, and after the challenge to quantify response magnitude, cross-system coordination, and recovery kinetics. This procedure is performed for observational research and does not assign treatment.
- OTHER
-
Multimodal Whole-Body Physiologic Monitoring
Participants will undergo multimodal longitudinal monitoring using research assessments that may include wearable sensors, electrocardiography, blood pressure, pulse oximetry, respiratory measurements, body composition, sleep and activity monitoring, mobility testing, symptom assessments, and point-of-care imaging. Measurements will be synchronized when feasible to characterize whole-body physiologic state and change over time. Study-generated measurements are observational and will not be used to direct treatment.
- OTHER
-
Research-Only Whole-Body Digital Twin Analysis
A version-controlled computational model will integrate each participant's longitudinal physiologic, functional, clinical, imaging, wearable, and optional biospecimen-derived data. The model will estimate whole-body resilience, organ-system interactions, physiologic reserve, and recovery trajectories. Model development will use a prespecified training sample, followed by locked validation in an independent sample. Digital-twin outputs are investigational, research-only, and will not be used for diagnosis or clinical decision-making.
Sponsors & Collaborators
-
Truway Health, Inc.
lead INDUSTRY
Principal Investigators
-
Gavin C Solomon, MD · Truway Health, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-08-31
- Primary Completion
- 2039-03-31
- Completion
- 2041-06-30
Countries
- United States
Study Locations
More Related Trials
-
Verily Clinical Study Watch Analytical Validation Study
NCT05534477 ·Status: ACTIVE_NOT_RECRUITING
-
A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation
NCT05296148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ECG Validation Study
NCT05445726 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study
NCT02768402 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
NCT06611579 ·Status: RECRUITING ·Phase: NA
-
MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
NCT00305240 ·Status: COMPLETED ·Phase: NA
-
Stroke Volume at Rest and During Exercise in Healthy Volunteers
NCT07318844 ·Status: COMPLETED ·Phase: NA
-
Mitral Insufficiency Reduction With Biventricular Pacing
NCT01242397 ·Status: UNKNOWN ·Phase: PHASE1
-
Rhythmic Risk of Type 1 Brugada Syndrome and Pulmonary Infundibulum Mapping
NCT03572881 ·Status: UNKNOWN ·Phase: NA
-
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias
NCT04750798 ·Status: RECRUITING
-
Cutaneous Heart Sounds Data Collection During Cardiac Resynchronization Therapy (CRT) Optimization Study
NCT01609985 ·Status: COMPLETED
-
Validation of Perin Health Patch ECG Monitoring Device Performance and Placement Accuracy
NCT07147920 ·Status: COMPLETED
-
Transcutaneous Vagal Nerve Stimulation to Prevent Tachyarrhythmias in Patients Early Following Myocardial Infarction
NCT05750108 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
NCT00957541 ·Status: COMPLETED ·Phase: PHASE2
-
3T MRI CIED Post-Approval Study
NCT02969395 ·Status: COMPLETED
-
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
NCT06753045 ·Status: RECRUITING
-
The Long COVID-19 Wearable Device Study
NCT05741112 ·Status: RECRUITING ·Phase: NA
-
Performance Assessment of a Remote Patient Monitoring Device
NCT02570906 ·Status: COMPLETED
-
Torque Device Evaluation
NCT07094256 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).
NCT07622446 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications
NCT00560768 ·Status: COMPLETED ·Phase: PHASE4
-
MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population
NCT05364541 ·Status: UNKNOWN ·Phase: NA
-
TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics
NCT00279981 ·Status: COMPLETED
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
NCT06183684 ·Status: RECRUITING ·Phase: NA
-
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
NCT05766943 ·Status: RECRUITING ·Phase: NA